GeraldBenjamin(Werthiem)WertheimMD
Pathology • Philadelphia, PAHematopathology, Anatomic Pathology, Clinical Pathology
Assistant Professor, Pathology & Laboratory Medicine, Perelman School of Medicine
Dr. Wertheim is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Spruce Street
6 Founders
Philadelphia, PA 19104Phone+1 215-662-6503
Education & Training
University of Pennsylvania Health SystemFellowship, Hematopathology, 2009 - 2011- University of Pennsylvania Health SystemResidency, Pathology-Anatomic and Clinical, 2005 - 2009
Perelman School of Medicine at the University of PennsylvaniaClass of 2005
Certifications & Licensure
NJ State Medical License 2019 - 2025
PA State Medical License 2005 - 2024- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Hematopathology
Publications & Presentations
PubMed
- 1 citationsGenomic profiling of pediatric hematologic malignancies and diagnosis of cancer predisposition syndromes: tumoronlypaired tumor-normal sequencing.Haley Newman, Mary Egan Clark, Derek Wong, Jinhua Wu, Garrett M Brodeur
Haematologica. 2024-09-01 - 1 citationsCondensate-Promoting ENL Mutation Drives Tumorigenesis In Vivo Through Dynamic Regulation of Histone Modifications and Gene Expression.Yiman Liu, Qinglan Li, Lele Song, Chujie Gong, Sylvia Tang
Cancer Discovery. 2024-08-02 - 3 citationsIdentification of TP53 germline variants in pediatric patients undergoing tumor testing: strategy and prevalence.Minjie Luo, Derek Wong, Kristin Zelley, Jinhua Wu, Jeffery Schubert
Journal of the National Cancer Institute. 2024-08-01
Abstracts/Posters
- DYRK1A Is Regulated By Oncogenic KMT2A and Required for Survival of KMT2A-Rearranged Acute Lymphoblastic LeukemiaGerald Wertheim, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Lncrna Morrbid Regulates Myeloid Cell Survival of AML Driven By a Combination of FLT3ITD and Epigenetic MutationsGerald Wertheim, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Oncogene-Independent Adaptation of Pre-B Cell Receptor Signaling Confers Drug Resistance and Signaling Plasticity in Ph-like ALLGerald Wertheim, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
